Skip to content

Longevity Health Holdings, Inc.: 10-Q filed 2025-08-14

What Longevity Health Holdings, Inc. reported in its quarterly report filed 2025-08-14 (fiscal Q2 2025): 43 published measures, 123 facts as tagged in accession 0000950170-25-108973.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-14
Fiscal period
fiscal Q2 2025
Accession
0000950170-25-108973 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Longevity Health Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-303,719,342USD
At 2024-12-311,473,980USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-307,456,876USD
At 2024-12-316,186,642USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-30-3,737,534USD
At 2025-03-31-3,805,285USD
At 2024-12-31-4,712,662USD
At 2024-06-30-1,371,772USD
At 2024-03-31-1,391,659USD
At 2023-12-3124,749,010USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,886,438USD91
2025-01-01 to 2025-06-30-3,392,305USD181
2024-04-01 to 2024-06-30-3,304,538USD91
2024-01-01 to 2024-06-30-6,575,497USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-1,589,143USD181
2024-01-01 to 2024-06-30-2,214,254USD182

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-04-01 to 2025-06-30503,612USD91
2025-01-01 to 2025-06-301,013,965USD181
2024-04-01 to 2024-06-3012,320USD91
2024-01-01 to 2024-06-3012,320USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-303,148,203USD181
2024-01-01 to 2024-06-302,248,864USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-165,000USD181
2024-01-01 to 2024-06-30-748,796USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-72,263,967USD
At 2024-12-31-68,871,662USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,209,809shares91
2025-01-01 to 2025-06-301,101,174shares181
2024-04-01 to 2024-06-30691,167shares91
2024-01-01 to 2024-06-30727,503shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,209,809shares91
2025-01-01 to 2025-06-301,101,174shares181
2024-04-01 to 2024-06-30691,167shares91
2024-01-01 to 2024-06-30727,503shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1.56USD/shares91
2025-01-01 to 2025-06-30-3.08USD/shares181
2024-04-01 to 2024-06-30-4.78USD/shares91
2024-01-01 to 2024-06-30-9.04USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1.56USD/shares91
2025-01-01 to 2025-06-30-3.08USD/shares181
2024-04-01 to 2024-06-30-4.78USD/shares91
2024-01-01 to 2024-06-30-9.04USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-04-01 to 2025-06-300USD91
2025-01-01 to 2025-06-300USD181
2024-04-01 to 2024-06-300USD91
2024-01-01 to 2024-06-300USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-30117,662USD
At 2024-12-31113,906USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-06-30309,152USD181
2024-01-01 to 2024-06-30375,169USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,858,604USD91
2025-01-01 to 2025-06-30-3,365,355USD181
2024-04-01 to 2024-06-30-1,191,487USD91
2024-01-01 to 2024-06-30-2,571,832USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-303,240,887USD
At 2024-12-31955,554USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,561USD91
2025-01-01 to 2025-06-307,554USD181
2024-04-01 to 2024-06-303,264USD91
2024-01-01 to 2024-06-3014,830USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-306,913,648USD
At 2024-12-315,876,705USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-06-304,590,542USD
At 2024-12-314,058,091USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-06-3017,367USD
At 2024-12-3119,641USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-3054,496USD
At 2024-12-314,096USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,161,262USD91
2025-01-01 to 2025-06-303,937,836USD181
2024-04-01 to 2024-06-301,203,515USD91
2024-01-01 to 2024-06-302,583,860USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-06-301,172,634USD
At 2024-12-31108,705USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30302,658USD91
2025-01-01 to 2025-06-30572,481USD181
2024-04-01 to 2024-06-3012,028USD91
2024-01-01 to 2024-06-3012,028USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-04-01 to 2025-06-30228,606USD91
2025-01-01 to 2025-06-30425,518USD181
2024-04-01 to 2024-06-30104,066USD91
2024-01-01 to 2024-06-30533,486USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-301,483,738shares
At 2024-12-31696,969shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-301,551,199USD
At 2024-12-31157,139USD
At 2024-06-302,198,275USD
At 2023-12-312,912,461USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3068,526,285USD
At 2024-12-3164,158,930USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-06-30343,426USD
At 2024-12-31384,879USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-30863,179USD
At 2024-12-31815,561USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-30745,517USD
At 2024-12-31701,655USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,886,438USD91
2025-01-01 to 2025-06-30-3,392,305USD181
2024-04-01 to 2024-06-30-3,304,538USD91
2024-01-01 to 2024-06-30-6,857,700USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-3,392,305USD181
2024-01-01 to 2024-06-30-6,857,700USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-04-01 to 2025-06-3022,184USD91
2025-01-01 to 2025-06-3046,136USD181
2024-04-01 to 2024-06-3023,530USD91
2024-01-01 to 2024-06-3047,061USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,137USD91
2025-01-01 to 2025-06-302,274USD181
2024-04-01 to 2024-06-301,132USD91
2024-01-01 to 2024-06-302,264USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-27,834USD91
2025-01-01 to 2025-06-30-26,950USD181
2024-04-01 to 2024-06-30-2,113,051USD91
2024-01-01 to 2024-06-30-4,285,868USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-307,554USD181
2024-01-01 to 2024-06-3014,830USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-06-303,397,476USD181
2024-01-01 to 2024-06-302,687,225USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-26,155USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-222,210USD181
2024-01-01 to 2024-06-30113,872USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30258,791USD181
2024-01-01 to 2024-06-30-321,816USD182

Inspect the source

Entity
Longevity Health Holdings, Inc. / CIK 0001842939
Captured
2026-09-21T17:37:49.979Z
SEC response SHA-256
33db7095b2d5ec482c7a1d00924c3102d456f2ff5cede2f410122a82954c4d25

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001842939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))